Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 1, 2006, Pages 143-151

  Wang, Dian ^a   Schultz, Christopher J ^a   Jursinic, Paul A ^a   Bialkowski, Mirek ^a   Zhu, X Ronald ^a   Brown, W Douglas ^a   Rand, Scott D ^a   Michel, Michelle A ^a   Campbell, Bruce H ^a   Wong, Stuart ^a   Li, X Allen ^a   Wilson, J Frank ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

18F fluorodeoxyglucose positron emission tomography; Head and neck cancer; Intensity modulated radiotherapy; Radiotherapy

Indexed keywords

BIOLOGICAL ORGANS; BIOMARKERS; CELLS; COMPUTERIZED TOMOGRAPHY; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY;

18 F-FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHY; HEAD-AND-NECK CANCER; INTENSITY-MODULATED RADIOTHERAPY;

RADIOTHERAPY;

FLUORODEOXYGLUCOSE F 18;

ACCURACY; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FACE MASK; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; IMMOBILIZATION; INTENSITY MODULATED RADIATION THERAPY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33645964284     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.11.048     Document Type: Article

References (24)

1. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Oncology Group phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
2. Staar S., Rudat V., Stuetzer H., et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy. Results of a multicenter randomized German trial in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 1161-1171
3. Skladowski K., Maciejewski B., Golen M., Pilecki B., Przeorek W., and Tarnawski R. Randomized clinical trial on 7-day continuous accelerated radiation (CAIR) of head and neck cancer-Report on 3-year tumor control and normal tissue toxicity. Radiother Oncol 55 (2000) 101-110
4. Eisbruch A. Clinical aspects of IMRT for head-and-neck cancer. Med Dosim 27 (2002) 99-104
5. Chao K.S. Protection of salivary gland function by intensity-modulated radiation therapy in patients with head and neck cancer. Semin Radiat Oncol 12 Suppl. 1 (2002) 20-25
6. Dawson L.A., Anzai Y., Marsh L., et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 46 (2000) 1117-1126
7. Lee N., Xia P., Fishbein N.J., et al. Intensity-modulated radiation therapy for head-and-neck cancer. The UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 57 (2003) 49-60
8. Chao K.S., Ozyigit G., Than B.N., et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 55 (2003) 312-321
9. Chao K.S., Deasy J.O., Markman J., et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy. Initial results. Int J Radiat Oncol Biol Phys 49 (2001) 907-916
10. Lin A., Kim H.M., Terrell J.E., et al. Quality of life after parotid-sparing IMRT for head-and-neck cancer. A prospective longitudinal study. Int J Radiat Oncol Biol Phys 57 (2003) 61-70
11. Kitagawa Y., Nishizawa S., Sano K., et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MR, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med 44 (2003) 198-206
12. Adams S., Baum R.P., Stuckensen T., et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 25 (1998) 1255-1260
13. Laubenbacher C., Saumweber D., Wagner-Manslau C., et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 36 (1995) 1747-1757
14. Kluetz P.G., Meltzer C.C., Villemange V.L., et al. Combined PET/CT imaging in oncology. Impact on patient management. Clin Positron Imaging 3 (2000) 223-230
15. Paulino A.C., and Johnstone P.A. FDG-PET in radiotherapy treatment planning. Pandora's box?. Int J Radiat Oncol Biol Phys 59 (2004) 4-5
16. Goerres G.W., Hany T.F., Kamel E., et al. Head and neck imaging with PET and PET/CT. Artifacts from dental metallic implants. Eur J Nucl Med Mod Imaging 29 (2002) 367-370
17. Heron D.E., Andrade R.S., Flickinger J., et al. Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancer cancers. A brief technical report. Int J Radiat Oncol Biol Phys 60 (2004) 1419-1424
18. Scarfone C., Lavely W.C., Cmelak A.J., et al. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med 45 (2004) 543-552
19. Nishioka T., Shiga T., Shirato H., et al. Image fusion between 18 FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys 53 (2002) 1051-1057
20. Daisne J., Duprez T., Weynant B., et al. Impact of image coregistration with computed tomography (CT), magnetic resonance (MR), and positron emission tomography with fluorodeoxyglucose (FDG-PET) on delineation of GTV's in oropharyngeal, laryngeal and hypopharyngeal tumors. Int J Radiat Oncol Biol Phys 54 Suppl (2002) 15-16
21. Ciernik F., Dizendorf E., Baumert B., et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT). A feasibility study. Int J Radiat Oncol Biol Phys 57 (2003) 853-863
22. Antoch G., Freudenberg L.S., Egeldorf T., et al. Focal tracer uptake. A potential artifact in contrasted-enhanced dual-modality PET/CT scans. J Nucl Med 43 (2002) 1339-1342
23. Daisne J.F., Sibomana M., Bol A., et al. Evaluation of a multimodality image (CT, MRI and PET) coregistration procedure on phantom and head and neck cancer patients. Accuracy, reproducibility and consistency. Radiother Oncol 69 (2003) 237-245
24. Di Martino E., Nowak B., Hassan H.A., et al. Diagnosis and staging of head and neck cancer. A comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg 126 (2000) 1457-1461